Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group

Published:2021-09-02 Issue:1 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Getz Kelly D.¹²^ORCID,Alonzo Todd A.³,Sung Lillian⁴,Meshinchi Soheil⁵,Gerbing Robert B.⁶,Raimondi Susana⁷,Hirsch Betsy⁸,Loken Michael⁹,Brodersen Lisa Eidenschink⁹,Kahwash Samir¹⁰,Choi John⁷,Kolb E. Anders¹¹,Gamis Alan¹²,Aplenc Richard¹²

Affiliation:

1. Children's Hospital of Philadelphia Division of Oncology Philadelphia Pennsylvania USA

2. Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

3. University of Southern California Los Angeles California USA

4. The Hospital for Sick Children Toronto Ontario Canada

5. Fred Hutchinson Cancer Research Center Seattle Washington USA

6. Children's Oncology Group Monrovia California USA

7. St. Jude Children's Research Hospital Memphis Tennessee USA

8. University of Minnesota Minneapolis Minnesota USA

9. Hematologics Inc Seattle Washington USA

10. Nationwide Children's Hospital Columbus Ohio USA

11. Alfred I. duPont Hospital for Children Wilmington Delaware USA